Nuance Pharma announces the completion of dosing for all NTM-001 Phase 1 clinical study participants in HKU Clinical Trials Centre

/PRNewswire/ -- Nuance Pharma ("the Company") announces the completion of dosing for all HNVs in the Phase I clinical study of its novel Ketorolac for IV...

Related Keywords

China ,Shanghai ,Hong Kong ,Chinese ,Mark Lotter ,Melissa Donnelly ,Vicky Lin ,Asia Pacific ,Markg Lotter ,Ipsos Medtech ,Nuance Pharma The Company ,Nuance Pharma ,Neumentum Inc ,Greater China ,Executive Chairman ,Postoperative Period ,Dual Wheel ,Public Relations Manager ,Nuance Pharma Limited ,